Article Details

Amgen readies KRAS-blocking cancer drug for FDA filing

Retrieved on: 2020-12-09 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

Amgen readies KRAS-blocking cancer drug for FDA filing. View article details on hiswai:

Excerpt

Piper Sandler's Raymond, for instance, predicts sotorasib sales may reach close to $1.4 billion within five years. Recommended Reading: <b>BioPharma</b> ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo